Essential thrombocytosis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview==Essential thrombocytosis is a rare idiopathic condition affecting about 24 for every million people in the world<ref>Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015</ref>. Although '''ET''' can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.<ref>Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.</ref> | ||
==Epidemiology== | ==Epidemiology== | ||
Essential thrombocytosis is a rare idiopathic condition affecting about 24 for every million people in the world<ref>Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015</ref>. Although '''ET''' can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.<ref>Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.</ref> | *Essential thrombocytosis is a rare idiopathic condition affecting about 24 for every million people in the world<ref>Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015</ref>. Although '''ET''' can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.<ref>Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.</ref> | ||
*ET has a bimodal presentation in that it presents in people in their 60's while the other peak occurs in the 30's. | |||
*Females in their third decade of life are slightly affected more than the males at same age, the male to female ratio being 1.5-2:1. Patients in the 6th decade of life usually have same incidence in both males and females | |||
==References== | ==References== | ||
Revision as of 14:25, 4 November 2015
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis epidemiology and demographics |
|
FDA on Essential thrombocytosis epidemiology and demographics |
|
CDC on Essential thrombocytosis epidemiology and demographics |
|
Essential thrombocytosis epidemiology and demographics in the news |
|
Blogs on Essential thrombocytosis epidemiology and demographics |
|
Risk calculators and risk factors for Essential thrombocytosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
==Overview==Essential thrombocytosis is a rare idiopathic condition affecting about 24 for every million people in the world[1]. Although ET can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.[2]
Epidemiology
- Essential thrombocytosis is a rare idiopathic condition affecting about 24 for every million people in the world[3]. Although ET can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.[4]
- ET has a bimodal presentation in that it presents in people in their 60's while the other peak occurs in the 30's.
- Females in their third decade of life are slightly affected more than the males at same age, the male to female ratio being 1.5-2:1. Patients in the 6th decade of life usually have same incidence in both males and females
References
- ↑ Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015
- ↑ Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.
- ↑ Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015
- ↑ Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.